Dark

Check out our API

AFIB
ACUTUS MEDICAL INC
stock OTC

EOD

Jul 23, 2026

0.000001USD-99.000%(-0.000099)8,746

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 20, 2022

10:41AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022 Benzinga

09:31AM EST BTIG Downgrades Acutus Medical to Neutral Benzinga

Jan 19, 2022

09:48AM EST Acutus Medical Plans Job Cuts; Preliminary Q4, FY21 Sales Exceed Estimates Benzinga

06:05AM EST Acutus Medical Sees Prelim. Q4 Sales $4.2M-$4.4M vs $3.99M Est., FY21 Sales $17.1M-$17.3M vs $16.91M Est. Benzinga

06:00AM EST Acutus Medical, Inc. (Acutus or the Company) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced a corporate restructuring as well as its preliminary unaudited revenue for the quarter and full year ended December 31, 2021. GlobeNewswire Inc

Jan 14, 2022

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2022 Benzinga

08:33AM EST Canaccord Genuity Downgrades Acutus Medical to Hold, Lowers Price Target to $3 Benzinga

Jan 13, 2022

11:44AM EST Acutus Medical's Pulsed Field Ablation System To Be Featured During 27th Annual AF Symposium Benzinga

06:30AM EST Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the companys attendance at the 27th Annual AF Symposium. GlobeNewswire Inc

Nov 30, 2021

04:03PM EST Overview Of Value Stocks In The Healthcare Sector Benzinga

Nov 12, 2021

03:12PM EST Mid-Afternoon Market Update: Dow Surges 150 Points; Team Shares Drop Benzinga

12:17PM EST Mid-Day Market Update: Everspin Jumps After Q3 Results; Acutus Medical Shares Plummet Benzinga

10:14AM EST Mid-Morning Market Update: Markets Rise; AstraZeneca's COVID-19 Vaccine Turns Profitable In Third Quarter Benzinga

10:05AM EST Benzinga's Top Ratings Upgrades, Downgrades For November 12, 2021 Benzinga

09:24AM EST JP Morgan Downgrades Acutus Medical to Underweight Benzinga

08:50AM EST Canaccord Genuity Maintains Buy on Acutus Medical, Lowers Price Target to $10 Benzinga

07:47AM EST The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares Benzinga

Nov 11, 2021

04:31PM EST Recap: Acutus Medical Q3 Earnings Benzinga

04:10PM EST Acutus Medical Initiates CE Mark Study For Focal Pulsed Field Ablation Therapy To Treat Atrial Fibrillation Benzinga

04:04PM EST Acutus Medical Q3 Adj. EPS $(0.87), Inline, Sales $4.60M Miss $5.68M Estimate Benzinga

04:02PM EST Acutus Medical Initiates CE Mark Study for Focal Pulsed Field GlobeNewswire Inc

04:01PM EST Acutus Medical, Inc. (Acutus or the Company) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the third quarter of 2021. GlobeNewswire Inc

03:55AM EST Earnings Scheduled For November 11, 2021 Benzinga

Oct 22, 2021

11:45AM EDT Goldman Sachs Initiates Coverage On Acutus Medical with Neutral Rating, Announces Price Target of $10 Benzinga

Oct 12, 2021

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 5, 2021

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Sep 30, 2021

11:39AM EDT Acutus Medical's Return On Capital Employed Overview Benzinga

Sep 28, 2021

08:18AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive Benzinga

08:16AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK To Develop Long-Acting HIV Treatments Benzinga

Sep 23, 2021

07:57AM EDT The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data Benzinga

Sep 22, 2021

07:45AM EDT The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs Benzinga

Sep 21, 2021

08:20AM EDT The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data Benzinga

Sep 16, 2021

07:48AM EDT The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study Benzinga

Sep 15, 2021

07:38AM EDT The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs Benzinga

Aug 12, 2021

04:35PM EDT Acutus Medical Q2 EPS $(1.02) Misses $(0.84) Estimate, Sales $4.70M Beat $4.15M Estimate Benzinga

04:02PM EDT Acutus Medical (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the appointment of Niamh Pellegrini to the Company's Board of Directors, effective August 10, 2021. GlobeNewswire Inc

04:01PM EDT Acutus Medical, Inc. (Acutus or the Company) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the second quarter of 2021. GlobeNewswire Inc

08:09AM EDT The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma Benzinga

04:14AM EDT Earnings Scheduled For August 12, 2021 Benzinga

Aug 11, 2021

08:01AM EDT Acutus Medical Announces FDA Clearance And CE Mark For AcQMap 8 Benzinga

08:00AM EDT AcQMap 8, Acutus Medicals Innovative Suite of GlobeNewswire Inc

Aug 9, 2021

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Aug 3, 2021

04:01PM EDT Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will attend investor meetings at the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on Tuesday, August 17, 2021. GlobeNewswire Inc

Jul 28, 2021

08:00AM EDT HRS 2021: EP Experts to Demonstrate the Benefits of Acutus GlobeNewswire Inc

Jul 27, 2021

11:13AM EDT AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias Benzinga

Jul 26, 2021

04:01PM EDT Acutus Medical, Inc. Announces Full Exercise of GlobeNewswire Inc

Jul 25, 2021

06:31PM EDT The Past Week's Most Notable Insider Buys: Blackstone, Cricut, Fast Acquisition And More Benzinga

Jul 21, 2021

09:09AM EDT Kerrisdale Advisers Reports In 13G Filing A 5.25 Stake In Acutus Medical Benzinga

07:52AM EDT The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay Benzinga

Jul 15, 2021

10:37AM EDT Canaccord Genuity Upgrades Acutus Medical to Buy, Raises Price Target to $18 Benzinga

Jul 14, 2021

07:35PM EDT Acutus Medical, Inc. Announces Pricing of Public Offering of GlobeNewswire Inc

Jul 13, 2021

08:05AM EDT The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data Benzinga

Jul 12, 2021

04:30PM EDT Acutus Medical Files For Offering Of 5.5M Shares Of Common Stock Benzinga

04:30PM EDT Acutus Medical, Inc. (Acutus or the Company) (Nasdaq: AFIB) today announced it has commenced an underwritten public offering of 5,500,000 shares of its common stock. All of the shares of common stock are being offered by Acutus. In addition, Acutus expects to grant the underwriters a 30-day option to purchase up to an additional 825,000 shares of its common stock in the offering. GlobeNewswire Inc

04:14PM EDT Acutus Medical Filing Shows Registration For 5.5M Common Stock Offering Benzinga

04:02PM EDT Acutus Medical Sees Q2 Prelim. Sales $4.6M-$4.7M Vs. $4.15M Est. Benzinga

04:02PM EDT Acutus Medical, Inc. (Acutus or the Company) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited results for the second quarter of 2021. GlobeNewswire Inc

Jun 28, 2021

12:21PM EDT Acutus Medical National Institutes Of Health ClinicalTrials.gov Study Record Detail For Co.'s 'AcQBlate Force Sensing Ablation System Study for Atrial Fibrillation (AcQForce AF-EU)' Benzinga

May 28, 2021

11:06AM EDT ROCE Insights For Acutus Medical Benzinga

May 27, 2021

09:18AM EDT Acutus Medical Receives Green Signal From FDA To Start AcQBlate Atrial Fibrillation Trial Benzinga

08:01AM EDT Acutus Medical Receives FDA Approval To Initiate US Atrial Fibrillation IDE Trial With AcQBlate FORCE Sensing Ablation System Benzinga

08:00AM EDT Acutus Medical Receives FDA Approval to Initiate US Atrial GlobeNewswire Inc

May 20, 2021

04:01PM EDT Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will participate at the 41st Annual William Blair Growth Stock Conference on Thursday, June 3, 2021 at 12:20 p.m. Eastern Time. GlobeNewswire Inc

May 12, 2021

04:19PM EDT Acutus Medical Announces CE Mark Approval For Suite Of EP Products In Europe, Which Includes AcQCross Benzinga

04:13PM EDT Acutus Medical Sees Q2 Sales $3.8M-$5.0M Vs. $4.56M Est., FY21 Sales $22M-$30M Vs. $24.49M Est. Benzinga

04:12PM EDT Acutus Medical Q1 Sales $3.60M Beat $2.77M Estimate Benzinga

04:05PM EDT Acutus Medical Announces CE Mark Approval for Suite of Next GlobeNewswire Inc

04:01PM EDT Acutus Medical, Inc. (Acutus or the Company) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter of 2021. GlobeNewswire Inc

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

04:22AM EDT Earnings Scheduled For May 12, 2021 Benzinga

May 11, 2021

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

May 7, 2021

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

May 6, 2021

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

May 5, 2021

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

Apr 28, 2021

04:01PM EDT Acutus Medical to Announce First Quarter 2021 Financial Results GlobeNewswire Inc

Apr 20, 2021

04:01PM EDT Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will participate at the following upcoming investor conferences: GlobeNewswire Inc

Apr 14, 2021

07:51AM EDT The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead Benzinga

Apr 13, 2021

08:16AM EDT The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug Benzinga

08:01AM EDT Acutus Medical Announces FDA Clearance Of AcQCross Suite Of Universal Transseptal Crossing Devices Benzinga

08:00AM EDT Acutus Medical Announces FDA Clearance of GlobeNewswire Inc

Apr 5, 2021

08:01AM EDT Acutus Medical Initiates its IDE Therapy Trial with the AcQBlate FORCE Sensing Ablation System Benzinga

08:00AM EDT Acutus Medical Initiates First IDE Therapy Trial with the GlobeNewswire Inc

Mar 30, 2021

04:01PM EDT Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13, 2021 at 3:45 p.m. Eastern Time. GlobeNewswire Inc

Mar 19, 2021

12:00PM EDT Canaccord Genuity Maintains Hold on Acutus Medical, Lowers Price Target to $16 Benzinga

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For March 19, 2021 Benzinga

08:29AM EDT William Blair Downgrades Acutus Medical to Market Perform Benzinga

06:59AM EDT JP Morgan Downgrades Acutus Medical to Neutral, Announces $19 Price Target Benzinga

Mar 18, 2021

07:07AM EDT Earnings Scheduled For March 18, 2021 Benzinga

06:01AM EDT Acutus Medical Q4 EPS $(0.89) Misses $(0.72) Estimate, Sales $2.60M Miss $3.60M Estimate Benzinga

06:00AM EDT Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the fourth quarter and full year ended December 31, 2020. GlobeNewswire Inc

06:00AM EDT Acutus Medical (Nasdaq: AFIB) today announced the appointment of John Sheridan to the Company's Board of Directors effective March 17, 2021. GlobeNewswire Inc

Mar 17, 2021

10:58PM EDT Acutus Medical Announces Earnings Call Time Change; Fourth Quarter GlobeNewswire Inc

Mar 14, 2021

08:14AM EDT Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations Benzinga

Mar 4, 2021

04:01PM EST Acutus Medical to Announce Fourth Quarter and Full Year 2020 GlobeNewswire Inc

Mar 2, 2021

08:27AM EST Acutus Medical Says Receives Vizient Innovative Technology Contract; Terms Not Disclosed Benzinga

08:18AM EST Acutus Medical Names Duane Wilder CCO Benzinga

08:00AM EST Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the appointment of Duane Wilder as the companys Chief Commercial Officer. GlobeNewswire Inc

08:00AM EST Acutus Medical Receives Vizient Innovative Technology Contract GlobeNewswire Inc

Feb 26, 2021

08:17AM EST The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida Benzinga

Feb 25, 2021

08:08AM EST The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga

Feb 24, 2021

07:30AM EST The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO Benzinga

Feb 9, 2021

04:03PM EST Acutus Medical Appoints David Roman CFO Benzinga

04:01PM EST -- David Roman appointed Chief Financial Officer -- Daniella Cramp to join Board of Directors GlobeNewswire Inc

Feb 4, 2021

04:01PM EST Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021 at 2:00 p.m. Eastern Time. GlobeNewswire Inc

Jan 28, 2021

08:00AM EST Acutus Medical Suite of EP Products To Be Featured During Recorded GlobeNewswire Inc

Jan 14, 2021

11:10AM EST B of A Securities Downgrades Acutus Medical to Neutral Benzinga

Jan 13, 2021

08:22AM EST Acutus Medical Sees Preliminary Unaudited Revenue To Be In Range Of $2.4 Mln-$2.6 Mln For Q4 RTTNews

08:06AM EST Acutus Medical Confirms Earlier Guidance Report; Shares DOwn 8.76% Benzinga

08:00AM EST Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited revenue results for the quarter and full year ended December 31, 2020. GlobeNewswire Inc

06:10AM EST Acutus Medical 8-K Shows Expectation For Q4 Guidance $2.4M-$2.6M vs $5M Estimate; Sees FY20 Sales $8.3M-$8.5M vs $11M Est. Benzinga

Dec 28, 2020

04:45PM EST Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that its management will present at the upcoming J.P. Morgan 39th Annual Healthcare Conference on Wednesday, January 13, 2021 at 10:00 a.m. Eastern Time. GlobeNewswire Inc

Dec 10, 2020

08:05AM EST Acutus Medical Announces CE Mark And European Launch Of AcQCross Transseptal System Benzinga

08:00AM EST Acutus Medical Announces CE Mark and European Launch of GlobeNewswire Inc

Dec 7, 2020

08:17AM EST Acutus Medical Unveils AcQBlate Force Sensing Ablation System In Europe RTTNews

08:00AM EST Acutus Medical Launches AcQBlate Force Sensing GlobeNewswire Inc

Nov 12, 2020

04:06PM EST Acutus Medical Q3 EPS $(0.91) Beats $(0.99) Estimate, Sales $2.30M Miss $3.02M Estimate Benzinga

04:02PM EST Steven Mickelsen, MD, Joins Acutus Medical as Chief Translational GlobeNewswire Inc

04:01PM EST Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the third quarter of 2020. GlobeNewswire Inc

04:18AM EST Earnings Scheduled For November 12, 2020 Benzinga

Nov 6, 2020

07:47AM EST The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold Benzinga

Sep 18, 2020

01:03PM EDT Earnings Recap For The Week Of September 18 Benzinga

Sep 17, 2020

04:03PM EDT Acutus Medical Q2 EPS $(32.24) Does Not Compare To $(1.03) Estimate, Sales $1.10M Inline Benzinga

04:02PM EDT Acutus Medical Announces FDA Clearance Of AcQMap 3D Imaging & Mapping Catheter Benzinga

04:01PM EDT Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), today reported financial results for its second quarter ended June 30, 2020. GlobeNewswire Inc

04:01PM EDT Acutus Medical Announces FDA Clearance of Second-Generation AcQMap GlobeNewswire Inc

04:04AM EDT Earnings Scheduled For September 17, 2020 Benzinga

Sep 8, 2020

08:38AM EDT Acutus Medical Reports Pulse Field Ablation Program, Initial Pre-Clinical Results Benzinga

08:30AM EDT Acutus Medical Announces Pulse Field Ablation Program and Initial GlobeNewswire Inc

Sep 3, 2020

04:01PM EDT Acutus Medical, Inc. (Acutus) (Nasdaq: AFIB), today announced it will release its financial results for the second quarter of 2020 after market close on Thursday, September 17, 2020. In conjunction with the release, Acutus will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights. GlobeNewswire Inc

Aug 31, 2020

09:31AM EDT Benzinga's Top Upgrades, Downgrades For August 31, 2020 Benzinga

07:31AM EDT William Blair Initiates Coverage On Acutus Medical with Outperform Rating Benzinga

07:28AM EDT Canaccord Genuity Initiates Coverage On Acutus Medical with Hold Rating, Announces Price Target of $30 Benzinga

07:26AM EDT B of A Securities Initiates Coverage On Acutus Medical with Buy Rating, Announces Price Target of $38 Benzinga

05:45AM EDT JP Morgan Initiates Coverage On Acutus Medical with Overweight Rating, Announces Price Target of $39 Benzinga

Aug 30, 2020

08:24AM EDT The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing Benzinga

Aug 20, 2020

04:21PM EDT Deerfield Management Company Reports 17.14% Active Stake In Acutus Medical Benzinga

Aug 18, 2020

04:37PM EDT OrbiMed Advisors Reports 20.9% Active Stake In Acutus Medical Benzinga

Aug 10, 2020

04:42PM EDT Acutus Medical Announces Closing of Initial Public Offering and GlobeNewswire Inc

Aug 6, 2020

01:20PM EDT Acutus Medical Shares Open For Trade At $24.11; IPO Priced At $18/Share Benzinga

08:56AM EDT Acutus Medical Shares Expected To Open For Quote At 10:10 a.m. EDT; Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced At $18/Share Benzinga

Aug 5, 2020

09:04PM EDT Acutus Medical Prices IPO Of 8.82 Mln Shares At $18.00/shr RTTNews

Share